Geneva Partners, LLC’s Regeneron Pharmaceuticals Position
Does Geneva Partners, LLC own Regeneron Pharmaceuticals (REGN)? Not currently — the last reported position was 3.5K shares worth $2M in Q2 2020; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$2M
Q2 2020
Shares
3.5K
% of Portfolio
+1.54%
Quarters Held
1
position exited
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2020 | 3.5K | $2M | +1.54% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Geneva Partners, LLC’s full portfolio or all institutional holders of REGN.